Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70 (0.87%) Dr Reddys Laboratories informs about disclosure
Date: 28-07-2021Dr Reddys Laboratories has informed that the Company has filed its unaudited condensed consolidated interim financial statements prepared under IFRS in Form 6-K for the quarter ended June 30, 2021, with the United States Securities and Exchange Commission on July 27, 2021. A copy of the Form 6- K is attached.
The above information is a part of company’s filings submitted to BSE.